Development of relugolix combination therapy as a medical treatment option for women with uterine fibroids or endometriosis

Treatment of uterine fibroids (UF) and endometriosis (EM) has relied on the surgical skills of gynecologists to improve symptoms and potentially alter the course of these debilitating diseases. Medical management of symptoms for both diseases leverages combined hormonal contraceptives used off label...

Descripción completa

Detalles Bibliográficos
Autores principales: Arjona Ferreira, Juan C., Migoya, Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Special Issue
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201285/
https://www.ncbi.nlm.nih.gov/pubmed/37223761
http://dx.doi.org/10.1016/j.xfre.2022.11.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201285/
https://www.ncbi.nlm.nih.gov/pubmed/37223761
http://dx.doi.org/10.1016/j.xfre.2022.11.010

Ejemplares similares